Cargando…
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease
BACKGROUND: Previous studies have demonstrated that regulatory T cells (Tregs) play a protective role in the pathogenesis of chronic graft-versus-host disease (cGVHD). Tregs constitutively express the gene of the transcription factor Foxp3 whose CNS2 region is heavily methylated in conventional CD4(...
Autores principales: | Fransolet, Gilles, Ehx, Grégory, Somja, Joan, Delens, Loïc, Hannon, Muriel, Muller, Joséphine, Dubois, Sophie, Drion, Pierre, Caers, Jo, Humblet-Baron, Stéphanie, Delvenne, Philippe, Beguin, Yves, Conteduca, Giuseppina, Baron, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932697/ https://www.ncbi.nlm.nih.gov/pubmed/27377819 http://dx.doi.org/10.1186/s13045-016-0281-2 |
Ejemplares similares
-
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
por: Ehx, Grégory, et al.
Publicado: (2018) -
Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease
por: Belle, Ludovic, et al.
Publicado: (2016) -
Validation of a multicolor staining to monitor (phospho)STAT5 levels in regulatory T-cell subsets
por: Ehx, Grégory, et al.
Publicado: (2015) -
Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
por: Servais, Sophie, et al.
Publicado: (2015) -
Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
por: Grégoire, Céline, et al.
Publicado: (2019)